PRODUCTS
PIPELINE
Amarin is progressing several development candidates for CNS and cardiovascular disease. The pipeline contains a mix of new chemical entities (NCEs) and improved outcome formulations of established drugs, all addressing unmet patient needs. To learn more about each program or indication select an item from the chart below.
